EGR1 and anemia (phenotype): EGR1−/− mice treated with the DNA alkylating agent, N-ethyl-nitrosourea, develop immature T-cell lymphomas or myeloproliferative disorders, characterized by elevated WBC, anemia with ineffective erythropoiesis and thrombocytopenia [61].